Dixon Mitchell Investment Counsel’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-187
| Closed | -$39.9K | – | 76 |
|
|
2025
Q2 | $39.9K | Hold |
187
| – | – | ﹤0.01% | 59 |
|
|
2025
Q1 | $39.2K | Sell |
187
-981
| -84% | -$58.7K | ﹤0.01% | 62 |
|
|
2024
Q4 | $52.4K | Buy |
1,168
+326
| +39% | +$18.3K | ﹤0.01% | 66 |
|
|
2024
Q3 | $52.9K | Sell |
842
-955
| -53% | -$55.7K | ﹤0.01% | 65 |
|
|
2024
Q2 | $106K | Sell |
1,797
-692,458
| -100% | -$43.3M | 0.01% | 61 |
|
|
2024
Q1 | $55.4M | Buy |
694,255
+11,402
| +2% | +$871K | 2.76% | 14 |
|
|
2023
Q4 | $53.9M | Sell |
682,853
-15,279
| -2% | -$1.09M | 2.87% | 13 |
|
|
2023
Q3 | $48.7M | Sell |
698,132
-6,450
| -0.9% | -$457K | 2.95% | 14 |
|
|
2023
Q2 | $48.7M | Buy |
704,582
+117,822
| +20% | +$8.38M | 2.79% | 15 |
|
|
2023
Q1 | $43.6M | Buy |
586,760
+173,018
| +42% | +$14.5M | 2.73% | 17 |
|
|
2022
Q4 | $38.6M | Buy |
413,742
+2,578
| +0.6% | +$249K | 2.58% | 18 |
|
|
2022
Q3 | $39.2M | Buy |
411,164
+121,800
| +42% | +$12.1M | 2.92% | 16 |
|
|
2022
Q2 | $26.8M | Buy |
289,364
+11,265
| +4% | +$1.1M | 1.91% | 21 |
|
|
2022
Q1 | $28.1M | Sell |
278,099
-28,843
| -9% | -$3.03M | 1.68% | 21 |
|
|
2021
Q4 | $31.7M | Buy |
306,942
+7,056
| +2% | +$652K | 1.97% | 19 |
|
|
2021
Q3 | $25.4M | Buy |
299,886
+8,714
| +3% | +$730K | 1.78% | 20 |
|
|
2021
Q2 | $24.3M | Buy |
291,172
+8,151
| +3% | +$667K | 1.8% | 20 |
|
|
2021
Q1 | $21.3M | Sell |
283,021
-16,108
| -5% | -$1.17M | 1.76% | 20 |
|
|
2020
Q4 | $20.4M | Sell |
299,129
-1,649
| -0.5% | -$107K | 1.77% | 21 |
|
|
2020
Q3 | $17.6M | Buy |
300,778
+3,186
| +1% | +$198K | 1.73% | 19 |
|
|
2020
Q2 | $19.3M | Sell |
297,592
-1,692
| -0.6% | -$107K | 2.12% | 17 |
|
|
2020
Q1 | $17.8M | Buy |
299,284
+4,029
| +1% | +$269K | 2.24% | 17 |
|
|
2019
Q4 | $21.9M | Buy |
295,255
+20,673
| +8% | +$1.45M | 2.33% | 14 |
|
|
2019
Q3 | $17.3M | Sell |
274,582
-4,743
| -2% | -$281K | 1.97% | 17 |
|
|
2019
Q2 | $15.2M | Sell |
279,325
-4,727
| -2% | -$255K | 1.72% | 20 |
|
|
2019
Q1 | $15.3M | Sell |
284,052
-7,253
| -2% | -$448K | 1.81% | 19 |
|
|
2018
Q4 | $19.1M | Sell |
291,305
-4,102
| -1% | -$306K | 2.56% | 13 |
|
|
2018
Q3 | $23.3M | Sell |
295,407
-1,798
| -0.6% | -$129K | 2.71% | 13 |
|
|
2018
Q2 | $19.1M | Sell |
297,205
-22,336
| -7% | -$1.47M | 2.42% | 14 |
|
|
2018
Q1 | $19.9M | Buy |
319,541
+11,098
| +4% | +$796K | 2.63% | 14 |
|
|
2017
Q4 | $22.4M | Buy |
308,443
+13,660
| +5% | +$993K | 2.86% | 13 |
|
|
2017
Q3 | $24M | Buy |
294,783
+638
| +0.2% | +$50.5K | 3.2% | 12 |
|
|
2017
Q2 | $23.7M | Buy |
294,145
+8,295
| +3% | +$655K | 3.34% | 11 |
|
|
2017
Q1 | $22.4M | Buy |
285,850
+66,492
| +30% | +$5.31M | 3.25% | 12 |
|
|
2016
Q4 | $17.3M | Buy |
219,358
+32,485
| +17% | +$2.63M | 2.61% | 14 |
|
|
2016
Q3 | $16.6M | Buy |
186,873
+23,573
| +14% | +$2.23M | 2.59% | 16 |
|
|
2016
Q2 | $15.6M | Buy |
163,300
+25,278
| +18% | +$2.52M | 2.59% | 17 |
|
|
2016
Q1 | $14.3M | Buy |
138,022
+81,193
| +143% | +$7.89M | 2.32% | 17 |
|
|
2015
Q4 | $5.56M | Buy |
56,829
+1,852
| +3% | +$181K | 0.94% | 33 |
|
|
2015
Q3 | $5.3M | Buy |
+54,977
| New | +$5.78M | 0.92% | 35 |
|
Other funds holding CVS
Dixon Mitchell Investment Counsel's CVS Position: Q3 2025 in Review
Dixon Mitchell Investment Counsel sold out of CVS Health (CVS) in Q3 2025, closing a stake of 187 shares — an estimated $39.9K sold.
Dixon Mitchell Investment Counsel first reported a position in CVS in Q3 2015 and held it in 40 quarters. The position peaked at $55.4M in Q1 2024. 1,835 funds tracked by Wall St. Rank hold CVS as of Q3 2025.
- Dixon Mitchell Investment Counsel reported no remaining CVS Health position as of Q3 2025 after selling out during the quarter.
- Dixon Mitchell Investment Counsel sold 187 CVS Health shares in Q3 2025, an estimated $39.9K.
- Dixon Mitchell Investment Counsel first reported a position in CVS Health in Q3 2015 and held it in 40 quarters.
- Dixon Mitchell Investment Counsel's CVS Health position peaked at $55.4M in Q1 2024.
- 1,835 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.
Based on Dixon Mitchell Investment Counsel's 13F filing for Q3 2025, filed 13 Nov 2025.